Perceived quality of life using IMPACT-III in a sample of Colombian children with IBD in remission: a cross-sectional study

Viviana Parra-Izquierdo; Juan Sebastián Frías-Ordoñez; Fabián E. Puentes M.; Consuelo Romero-Sánchez; Diana Mora; Fernando Sarmiento; Johon Francisco Garcés Camacho; Carlos Cuadros; Melquisedec Vargas; Carolina Samper; Manuel Alonso Ardila-Báez; Mariastella Serrano

doi:10.47892/rgp.2025.452.1900

Authors

Viviana Parra-Izquierdo International Hospital of Colombia, Bucaramanga, Colombia; Cellular and Molecular Immunology Group (INMUBO), Universidad El Bosque, Bogotá, Colombia; Colombian Foundation of Inflammatory Bowel Disease (FUNEIICO), Colombia. https://orcid.org/0000-0003-2361-1018
Juan Sebastián Frías-Ordoñez International Hospital of Colombia, Bucaramanga, Colombia. https://orcid.org/0000-0003-2735-2922
Fabián E. Puentes M. Colombian Foundation of Inflammatory Bowel Disease (FUNEIICO), Colombia; University of Caldas. Union of Surgeons. ODO. Zentria Salud. Manizales. Caldas. Colombia. https://orcid.org/0000-0002-6769-0048
Consuelo Romero-Sánchez Cellular and Molecular Immunology Group (INMUBO), Universidad El Bosque, Bogotá, Colombia. https://orcid.org/0000-0002-6973-7639
Diana Mora Hospital of La Misericordia. Bogota. Colombia. https://orcid.org/0000-0002-2892-5377
Fernando Sarmiento Hospital of La Misericordia. Bogota. Colombia. https://orcid.org/0000-0003-1441-3255
Johon Francisco Garcés Camacho International Hospital of Colombia, Bucaramanga, Colombia. https://orcid.org/0000-0002-3223-7622
Carlos Cuadros International Hospital of Colombia, Bucaramanga, Colombia. https://orcid.org/0000-0001-5920-1614
Melquisedec Vargas GastroKids SAS. Pereira. Colombia. https://orcid.org/0000-0002-5747-9601
Carolina Samper Colombian Foundation of Inflammatory Bowel Disease (FUNEIICO), Colombia. https://orcid.org/0000-0001-6738-2400
Manuel Alonso Ardila-Báez Sabana University, Chía, Cundinamarca, Colombia. https://orcid.org/0000-0001-5057-3497
Mariastella Serrano Division of Pediatric Gastroenterology, Hepatology and Nutrition, Georgetown University, Washington DC. https://orcid.org/0000-0001-8545-4949

DOI:

https://doi.org/10.47892/rgp.2025.452.1900

Keywords:

Inflammatory Bowel Diseases, Colitis, Ulcerative, Crohn Disease, Quality of Life, Surveys and Questionnaires

Abstract

Introduction: No data on quality of life (QoL) in paediatric IBD in Colombia. The aim of this study was to determine QoL using the IMPACT-III questionnaire in a sample of patients from different centres. Materials and methods: Cross-sectional study of paediatric IBD patients followed in 3 centres in different cities, between June and November 2022. Eligible subjects were identified, information was collected on different dates, and the IMPACT-III questionnaire (score ranges from 35 to 175, with higher scores indicating better QoL) was administered once. Results: 33 patients were included. 23/33 (69.7%) female, mean age 14.9 (range 6-17.9) years. 94% with inactive or mild disease. 20 patients with ulcerative colitis (UC), 13 with Crohn's disease (CD). The median score in UC was 147 (122-152), while in CD it was 126 (105-135). Systemic symptoms and emotional functioning were most affected, with median scores of 13 (12-14) and 27 (20-31) in UC and 11 (9-11) and 23 (20-26) in CD. No statistically significant differences were observed. Conclusions: The quality of life of children with IBD is challenging due to several factors. More support and education is needed for these patients.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Author Biographies

Fabián E. Puentes M., Colombian Foundation of Inflammatory Bowel Disease (FUNEIICO), Colombia; University of Caldas. Union of Surgeons. ODO. Zentria Salud. Manizales. Caldas. Colombia.

Consuelo Romero-Sánchez, Cellular and Molecular Immunology Group (INMUBO), Universidad El Bosque, Bogotá, Colombia.

Carolina Samper, Colombian Foundation of Inflammatory Bowel Disease (FUNEIICO), Colombia.

Mariastella Serrano, Division of Pediatric Gastroenterology, Hepatology and Nutrition, Georgetown University, Washington DC.

References

Malaty HM, Fan X, Opekun AR, Thibodeaux C, Ferry GD. Rising incidence of inflammatory bowel disease among children: a 12-year study. J Pediatr Gastroenterol Nutr. 2010;50(1):27-31. doi: 10.1097/MPG.0b013e3181b99baa.

Jin HY, Lim JS, Lee Y, Choi Y, Oh SH, Kim KM, et al. Growth, puberty, and bone health in children and adolescents with inflammatory bowel disease. BMC Pediatr. 2021;21(1):35. doi: 10.1186/s12887-021-02496-4.

Mouratidou N, Malmborg P, Sachs MC, Askling J, Ekbom A, Neovius M, et al. Adult height in patients with childhoodonset inflammatory bowel disease: a nationwide populationbased cohort study. Aliment Pharmacol Ther. 2020;51(8):789- 800. doi: 10.1111/apt.15667.

Parra-Izquierdo V, Frías-Ordoñez JS, Márquez JR, PuentesManosalva FE, Sarmiento F, García-Duperly R, et al. [Healthrelated quality of life by IBDQ-32 in colombian patients with inflammatory bowel disease in remission: A cross-sectional study]. Rev Gastroenterol Peru. 2023;43(2):95-103. doi: 10.47892/rgp.2023.432.1513.

Kourkoutas E, Georgiadi M, Plexousakis S. Quality of life of children with chronic illnesses: A Review of the Literature. Procedia Soc. Behav. Sci. 2010;2(2):4763-7. doi: 10.1016/j. sbspro.2010.03.765.

Grant A, MacIntyre B, Kappelman MD, Otley AR. A New Domain Structure for the IMPACT-III Health-related Quality of life Tool for Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 2020;71(4):494-500. doi: 10.1097/ MPG.0000000000002824.

Otley A, Smith C, Nicholas D, Munk M, Avolio J, Sherman PM, et al. The IMPACT questionnaire: a valid measure of health-related quality of life in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2002;35(4):557-63. doi: 10.1097/00005176-200210000-00018.

Guyatt G, Mitchell A, Irvine EJ, Singer J, Williams N, Goodacre R, et al. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology. 1989;96(3):804-10.

Loonen HJ, Grootenhuis MA, Last BF, Koopman HM. Quality of life in paediatric inflammatory bowel disease measured by a generic and a disease-specific questionnaire. Acta Paediatr Int J Paediatr. 2002;91(3):348-54. doi: 10.1080/08035250252834049.

Loonen HJ, Derkx BH, Otley AR. Measuring health-related quality of life of pediatric patients. J Pediatr Gastroenterol Nutr. 2001;32(5):523-6. doi: 10.1097/00005176-200105000- 00006.

Perrin JM, Kuhlthau K, Chughtai A, Romm D, Kirschner BS, Ferry GD, et al. Measuring quality of life in pediatric patients with inflammatory bowel disease: psychometric and clinical characteristics. J Pediatr Gastroenterol Nutr. 2008;46(2):164- 71. doi: 10.1097/MPG.0b013e31812f7f4e.

Larrosa-Haro A, Abundis-Castro L, Contreras MB, Gallo MJ, Peña-Quintana L, Targa Ferreira CH, et al. Epidemiologic trend of pediatric inflammatory bowel disease in Latin America: The Latin American Society for Pediatric Gastroenterology, Hepatology and Nutrition (LASPGHAN) Working Group. Rev Gastroenterol Mex (Engl Ed). 2020:S0375-0906(20)30120-8. doi: 10.1016/j.rgmx.2020.07.010.

Vicentín R, Wagener M, Pais AB, Contreras M, Orsi M. Oneyear prospective registry of inflammatory bowel disease in the Argentine pediatric population. Arch Argent Pediatr. 2017;115(6):533-540. English, Spanish. doi: 10.5546/aap.2017. eng.533.

Arcucci MS, Contreras MB, Gallo J, Antoniska MA, Busoni V, Tennina C, et al. Pediatric Inflammatory Bowel Disease: A Multicenter Study of Changing Trends in Argentina Over the Past 30 Years. Pediatr Gastroenterol Hepatol Nutr. 2022;25(3):218-227. doi: 10.5223/pghn.2022.25.3.218.

Parra-Izquierdo V, Flórez Sarmiento C, Frías-Ordoñez JS, Vargas M, Kock J, Lozano Escobar N, et al. Clinical and therapeutic characterisation of a multicentre cohort of patients with inflammatory bowel disease in Colombia. Gastroenterol Hepatol. 2023;46(8):585-593. doi: 10.1016/j. gastrohep.2022.11.006.

Juliao-Baños F, Puentes F, López R, Saffon MA, Reyes G, Parra V, et al. Characterization of inflammatory bowel disease in Colombia: Results of a national register. Rev Gastroenterol Mex (Engl Ed). 2021;86(2):153-162. English, Spanish. doi: 10.1016/j. rgmx.2020.05.005.

Turner D, Otley AR, Mack D, Hyams J, de Bruijne J, Uusoue K, et al. Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study. Gastroenterology. 2007;133(2):423-32. doi: 10.1053/j. gastro.2007.05.029.

Hyams JS, Ferry GD, Mandel FS, Gryboski JD, Kibort PM, Kirschner BS, et al. Development and validation of a pediatric Crohn’s disease activity index. J Pediatr Gastroenterol Nutr. 1991;12(4):439-47.

Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine (Phila Pa 1976). 2000;25(24):3186-91. doi: 10.1097/00007632-200012150-00014.

Likert R. A technique for the measurement of attitudes. Arch Psychol. 1932;22(4):55.

World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191-4. doi: 10.1001/jama.2013.281053.

Colombia, Ministerio de Salud. Resolucion Numero 8430 De 1993 [Internet]. Bogotá: MinSalud; 1993 [citado el 17 de enero de 2025]. Disponible en: https://www.minsalud.gov.co/ sites/rid/lists/bibliotecadigital/ride/de/dij/resolucion-8430- de-1993.pdf

Silverberg MS, Satsangi J, Ahmad T, Arnott IDR, Bernstein CN, Brant SR, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19 Suppl A:5A36A. doi: 10.1155/2005/269076.

Kugathasan S, Judd RH, Hoffmann RG, Heikenen J, Telega G, Khan F, et al. Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based study. J Pediatr. 2003;143(4):525-31. doi: 10.1067/s0022-3476(03)00444-x.

Jafari S, Otley A, Vahed H, Heidari E, Khakshour A, Tehranian S, et al. Validation of the persian version of impact-iii quality of life questionnaire in iranian children with inflammatory bowel disease. Inn J Pediatr. 2020;30(2):e86281. doi: 10.5812/ ijp.86281.

Gatti S, Del Baldo G, Catassi G, Faragalli A, Aloi M, Bramuzzo M, et al. Factors associated with quality of life in Italian children and adolescents with IBD. Sci Rep. 2021;11(1):18076. doi: 10.1038/s41598-021-97661-1.

Lee GW, Chew KS, Wong SY, Chong SY, Ong SY, Lee WS. Quality of life in Malaysian children with inflammatory bowel disease: An understudied population. J Paediatr Child Health. 2022;58(11):1972-1979. doi: 10.1111/jpc.16130.

Chouliaras G, Margoni D, Dimakou K, Fessatou S, Panayiotou I, Roma-Giannikou E. Disease impact on the quality of life of children with inflammatory bowel disease. World J Gastroenterol. 2017;23(6):1067-1075. doi: 10.3748/wjg.v23. i6.1067.

Kim S, Park S, Kang Y, Kim JE, Kang B, Choe BH, et al. Can We Estimate Quality of Life in Pediatric Inflammatory Bowel Disease Patients? An Asian Multicenter Study. J Pediatr Gastroenterol Nutr. 2019;68(1):45-49. doi: 10.1097/ MPG.0000000000002119.

Herrerias G, Barros JR, Lopes MA, Saad-Hossne R, Baima JP, Sassaki LY. N02 The importance of the multidisciplinary team (MDT) and its impact on quality of life and medication adherence in patients with Inflammatory Bowel Disease. J Crohns Colitis. 2022;16(Supplement_1):i618. doi: 10.1093/ ecco-jcc/jjab232.844.

Mackner LM, Greenley RN, Szigethy E, Herzer M, Deer K, Hommel KA. Psychosocial issues in pediatric inflammatory bowel disease: report of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2013;56(4):449-58. doi: 10.1097/ MPG.0b013e3182841263.

Werner H, Landolt MA, Buehr P, Koller R, Nydegger A, Spalinger J, et al. Validation of the IMPACT-III quality of life questionnaire in Swiss children with inflammatory bowel disease. J Crohns Colitis. 2014;8(7):641-8. doi: 10.1016/j. crohns.2013.11.025.

Abdovic S, Mocic Pavic A, Milosevic M, Persic M, Senecic-Cala I, Kolacek S. The IMPACT-III (HR) questionnaire: a valid measure of health-related quality of life in Croatian children with inflammatory bowel disease. J Crohns Colitis. 2013;7(11):908- 15. doi: 10.1016/j.crohns.2012.12.010.